A doctor says GLP-1 weight-loss drugs may protect the heart — but only for as long as people keep taking them

by Adrienne Erin

If you’ve been following the buzz around GLP-1 medications like Ozempic, Wegovy, and semaglutide, you’ve probably heard they’re being called game-changers—not just for weight loss, but for heart health, too. The headlines, the testimonials, and even your own doctor might make these drugs sound like a miracle pill. But what if I told you the benefits only last as long as you keep taking them? And quitting could mean you lose those improvements just as quickly as you gained them. Let’s dig into the reality behind these popular meds and what you can do to ensure lasting results. (Based on the insights of Dr. Bret Scher)

Key Takeaways

  • GLP-1 medications significantly lower the risk of heart attacks, strokes, and cardiovascular death while you’re taking them.
  • The benefits disappear rapidly after stopping the medication, often within 6 to 18 months.
  • Long-term use may not be feasible (or desirable) for everyone due to side effects, cost, and dependence.
  • Sustainable lifestyle changes are crucial if you want lasting improvements in weight and heart health.

1. GLP-1 Medications: More Than Just a Weight Loss Solution

You may recognize names like semaglutide, Wegovy, Ozempic, and Mounjaro—all GLP-1 receptor agonists. While originally developed for diabetes, these medications have quickly gained fame for helping people drop weight and reduce hunger. What’s less talked about is their i